Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis
Ist Teil von
The New England journal of medicine, 2017-06, Vol.376 (24), p.2329-2340
Ort / Verlag
United States: Massachusetts Medical Society
Erscheinungsjahr
2017
Quelle
MEDLINE
Beschreibungen/Notizen
Talaromyces marneffei
is a dimorphic fungus that causes substantial disease in Asia, especially among persons infected with the human immunodeficiency virus. In this randomized, controlled trial, initial therapy with amphotericin B was found to be superior to itraconazole.
The dimorphic fungus
Talaromyces
(previously
Penicillium
)
marneffei
causes a life-threatening mycosis in immunocompromised persons living in or traveling to Southeast Asia, China, and India.
1
Talaromycosis (previously penicilliosis) is a major cause of human immunodeficiency virus (HIV)–related death; its prevalence is surpassed only by the prevalence of tuberculosis and cryptococcosis,
2
and it leads to 4 to 15% of HIV-related hospital admissions in regions in which the disease is endemic.
3
–
7
Talaromycosis is increasingly diagnosed among patients who are not infected with HIV but who have other immunodeficiency conditions
8
and is reported to be the second most common cause of all . . .